Clinical trial
Impact of HPV Vaccine On The Prevalence Of Human Papillomavirus In Mouth And Vagina In Norway
NCT02934724 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of HPV Vaccine On The Prevalence Of Human Papillomavirus In Mouth And Vagina In Norway
- Lead sponsor
- Oslo University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- February 28, 2017
- Enrollment
- 315 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer, cervical intraepithelial neoplasia, oropharyngeal cancer